Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 2Endocrine 2Head & Neck 1CNS 1Breast 1

Conditions

Breast Neoplasms 1

Interventions

Specimen Handling 50Letrozole 44Fulvestrant 44Paclitaxel 39pembrolizumab 34Magnetic Resonance Spectroscopy 32Carboplatin 31Trastuzumab 27Biopsy 27ribociclib 26Capecitabine 24Anastrozole 24palbociclib 23exemestane 23trastuzumab deruxtecan 20pertuzumab 20Tamoxifen 20abemaciclib 19Cyclophosphamide 17Taxes 15Radiotherapy 15130-nm albumin-bound paclitaxel 12elacestrant 11Docetaxel 11Standard of Care 10Gemcitabine 10sacituzumab govitecan 9olaparib 9eribulin 9Radiation 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
gallium Ga 68 dotatate × Breast × 30 days × Clear all
NCT04529044 2026-06-05

177Lu-DOTATATE for the Treatment of Stage IV or Recurrent Breast Cancer

OHSU Knight Cancer Institute

Phase 2 Recruiting
10 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡